Literature DB >> 12244574

Mechanisms of cytotoxicity induced by horseradish peroxidase/indole-3-acetic acid gene therapy.

Olga Greco1, Gabi U Dachs, Gillian M Tozer, Chryso Kanthou.   

Abstract

We have previously proposed the horseradish peroxidase (HRP) and the non-toxic plant hormone indole-3-acetic acid (IAA) as a novel system for gene-directed enzyme/prodrug therapy (GDEPT). The cytotoxic potential of HRP/IAA GDEPT and the induction of a bystander effect were demonstrated in vitro under normoxic as well as hypoxic tumour conditions. To date, the chemical agents and the cellular targets involved in HRP/IAA-mediated toxicity have not been identified. In the present work, some of the molecular and morphological features of the cells treated with HRP/IAA gene therapy were analysed. Human T24 bladder carcinoma cells transiently transfected with the HRP cDNA and exposed to the prodrug IAA showed chromatin condensation, formation of apoptotic bodies, DNA fragmentation, and Annexin V binding. Similar effects were observed when the cells were incubated with the apoptotic agent cisplatin. Caspases appeared to be involved as effectors in HRP/IAA-mediated apoptosis, since treatment with a general caspase inhibitor decreased the fraction of cells with micronuclei (MN) by 30%, with fragmented DNA by 50%, and with condensed chromatin by 60%. However, very little degradation of one of the downstream targets of caspase-3, PARP, could be detected, and apoptosis alone did not appear to account for the killing levels measured with a clonogenic assay. The effect of HRP/IAA treatment on cell cycle progression was also investigated, and a rapid cytostatic effect, equally affecting all phases of the division cycle, was observed. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244574     DOI: 10.1002/jcb.10292

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Enzyme/Prodrug Systems for Cancer Gene Therapy.

Authors:  Obeid M Malekshah; Xuguang Chen; Alireza Nomani; Siddik Sarkar; Arash Hatefi
Journal:  Curr Pharmacol Rep       Date:  2016-10-19

2.  Identification and characterization of new long chain acyl-CoA dehydrogenases.

Authors:  Miao He; Zhengtong Pei; Al-Walid Mohsen; Paul Watkins; Geoffrey Murdoch; Paul P Van Veldhoven; Regina Ensenauer; Jerry Vockley
Journal:  Mol Genet Metab       Date:  2010-12-17       Impact factor: 4.797

3.  Apoptosis of pancreatic cancer BXPC-3 cells induced by indole-3-acetic acid in combination with horseradish peroxidase.

Authors:  Chen Huang; Li-Ying Liu; Tu-Sheng Song; Lei Ni; Ling Yang; Xiao-Yan Hu; Jing-Song Hu; Li-Ping Song; Yu Luo; Lu-Sheng Si
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

4.  Gene therapy with tumor-specific promoter mediated suicide gene plus IL-12 gene enhanced tumor inhibition and prolonged host survival in a murine model of Lewis lung carcinoma.

Authors:  Yu Xu; Jinxuan Hou; Zhengchun Liu; Haijun Yu; Wenjie Sun; Jie Xiong; Zhengkai Liao; Fuxiang Zhou; Conghua Xie; Yunfeng Zhou
Journal:  J Transl Med       Date:  2011-04-11       Impact factor: 5.531

Review 5.  An updated view on horseradish peroxidases: recombinant production and biotechnological applications.

Authors:  Florian W Krainer; Anton Glieder
Journal:  Appl Microbiol Biotechnol       Date:  2015-01-11       Impact factor: 4.813

6.  Enzyme prodrug therapy: cytotoxic potential of paracetamol turnover with recombinant horseradish peroxidase.

Authors:  Diana Humer; Oliver Spadiut
Journal:  Monatsh Chem       Date:  2021-10-05       Impact factor: 1.451

7.  Diagnostic Value of 1H NMR-Based Metabolomics in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Breast Cancer.

Authors:  Hanaa M Morad; Mohamed M Abou-Elzahab; Salah Aref; Ahmed M A El-Sokkary
Journal:  ACS Omega       Date:  2022-02-22

8.  Recombinant horseradish peroxidase variants for targeted cancer treatment.

Authors:  Günther Bonifert; Lisa Folkes; Christoph Gmeiner; Gabi Dachs; Oliver Spadiut
Journal:  Cancer Med       Date:  2016-03-15       Impact factor: 4.452

9.  Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive Indolic Compounds.

Authors:  Ana B Cerezo; Ruth Hornedo-Ortega; M Antonia Álvarez-Fernández; Ana M Troncoso; M Carmen García-Parrilla
Journal:  Nutrients       Date:  2017-03-08       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.